1.Validity and reliability of the Chinese version of the Kutcher Adolescent Depression Scale
Huiming ZHOU ; Nan HAO ; Yasong DU ; Yanyu LIU ; Yutong SUI ; Yanhua WANG ; Yanan CUI ; Qiuping ZHONG ; Xiujuan JIAO ; Yifeng WEI ; Stanley KUTCHER
Chinese Mental Health Journal 2015;(6):413-418
Objective:To assess the validity and reliability of the Chinese version of the eleven-item Kutcher Adolescent Depression Scale (KADS-11)in Chinese adolescents,calculate its optimal cut-off value and the sensi-tivity and specificity,and explore the possibility of providing a useful tool to assess the severity of adolescent de-pressive symptoms.Methods:Totally 3180 students aged 11 -17 years were selected from schools in 6 provinces and Shanghai.All of them were asked to complete the KADS-11 and Children Depression Inventory (CDI). Students whose CDI scores were above 19 (including 19)were diagnosed with the DSM-IV criteria of depressive disorder,73 students from Shanghai sample were assessed with KADS-11 and CDI to analyze the test-retest reliabil-ity 1 month later.Results:Exploratory factor analysis showed that KADS-11 had 2 factors,and confirmatory factor analysis tested proved the 2-factor model fit better than the one-factor model.The KADS-11 total scores were posi-tively correlated with CDI total scores (r =0.74,P <0.01 ),and the KADS-11 scores were higher in depressive group than those in non-depressive group.The mean area under the curve (AUC)of KADS-11was 0.94,the mean area under the curve of each item ranged from 0.7 to 0.9.The optimal cut-off point of KADS-11 was total score≥9,sensitivity and specificity were 89% and 90% respectively.The Cronbach's alpha coefficient of the KADS-11 was 0.84,the spilt-half reliability coefficient was 0.71 (P <0.01),and the test-retest coefficient was 0.77 (P <0.01).Conclusion:The KADS-11 is appropriate for Chinese adolescents because of its good validity,reliability and diagnosis accuracy,it could be used to assess depressive symptoms for adolescents.
2.Pioneer of prostate cancer: past, present and the future of FOXA1.
Mona TENG ; Stanley ZHOU ; Changmeng CAI ; Mathieu LUPIEN ; Housheng Hansen HE
Protein & Cell 2021;12(1):29-38
Prostate cancer is the most commonly diagnosed non-cutaneous cancers in North American men. While androgen deprivation has remained as the cornerstone of prostate cancer treatment, resistance ensues leading to lethal disease. Forkhead box A1 (FOXA1) encodes a pioneer factor that induces open chromatin conformation to allow the binding of other transcription factors. Through direct interactions with the Androgen Receptor (AR), FOXA1 helps to shape AR signaling that drives the growth and survival of normal prostate and prostate cancer cells. FOXA1 also possesses an AR-independent role of regulating epithelial-to-mesenchymal transition (EMT). In prostate cancer, mutations converge onto the coding sequence and cis-regulatory elements (CREs) of FOXA1, leading to functional alterations. In addition, FOXA1 activity in prostate cancer can be modulated post-translationally through various mechanisms such as LSD1-mediated protein demethylation. In this review, we describe the latest discoveries related to the function and regulation of FOXA1 in prostate cancer, pointing to their relevance to guide future clinical interventions.
Amino Acid Sequence
;
Epigenesis, Genetic
;
Epithelial-Mesenchymal Transition
;
Gene Expression Regulation, Neoplastic
;
Hepatocyte Nuclear Factor 3-alpha/metabolism*
;
Histone Demethylases/metabolism*
;
Histones/metabolism*
;
Humans
;
Male
;
Mutation
;
Prostate/pathology*
;
Prostatic Neoplasms/pathology*
;
Protein Binding
;
Protein Processing, Post-Translational
;
Receptors, Androgen/metabolism*
;
Signal Transduction
;
Transcription, Genetic